Among them, semaphorine 4D seems to be involved not only in rheumatoid arthritis (RA) pathogenesis but also in AS immune dysregulation, being able to act through the aryl-hydrocarbon receptor AhR pathway, thus increasing TH17 response and inhibiting the TREG counterpart [120]. This evidence concerns the gene AHR and rheumatoid arthritis.